Tumor initiation cells in non-small cell lung cancer (NSCLC) were reported by transcriptomic analysis to possess highly elevated expression of glycine decarboxylase (GLDC), which was found to induce striking changes in glycolysis and glycine/serine metabolism. Here, GLDC is linked to non-small cell lung carcinoma.